| Bioactivity | Clindamycin (hydrochloride monohydrate) (Standard) is the analytical standard of Clindamycin (hydrochloride monohydrate). This product is intended for research and analytical applications. Clindamycin hydrochloride monohydrate is an oral protein synthesis inhibitory agent that has the ability to suppress the expression of virulence factors in Staphylococcus aureus at sub-inhibitory concentrations (sub-MICs). Clindamycin hydrochloride monohydrate resistance results from enzymatic methylation of the antibiotic binding site in the 50S ribosomal subunit (23S rRNA). Clindamycin hydrochloride monohydrate decreases the production of Panton-Valentine leucocidin (PVL), toxic-shock-staphylococcal toxin (TSST-1) or alpha-haemolysin (Hla). |
| CAS | 58207-19-5 |
| Formula | C18H36Cl2N2O6S |
| Molar Mass | 479.46 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Clindamycin (hydrochloride monohydrate) (Standard)
CAS: 58207-19-5 F: C18H36Cl2N2O6S W: 479.46
Clindamycin (hydrochloride monohydrate) (Standard) is the analytical standard of Clindamycin (hydrochloride monohydrate)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.